Insight: FDA warned PIP on breast implant safety in 2000
implants were “adulterated” and citing at least 11 deviations from good manufacturing practices. The problems had to do with PIP’s saline implants, a different
Tag: FDA
Risky French breast implants not sold in U.S.
mplants that are part of a mass recall in France are not on the U.S. market. The potentially dangerous silicone-gel breast implants that are part of a mass
Vivus Drops as Diet Drug Ingredient Affiliated With Defects
Vivus Inc., maker of an experimental weight-loss pill, sank 8.7 percent in late trading after an ingredient in the medicine was shown to be associated with
The Human Chorionic Gonadotropin (hCG) Diet
hCG does not help people who are overweight or obese to lose extra pounds. So why do people lose weight on the hCG diet? Doctors say it’s not the hCG. People
FDA Yanks HCG Weight-Loss Agents from Market
HCG offers any extra benefit. “There is no substantial evidence HCG increases weight loss beyond that resulting from the recommended caloric restriction,” said
Contrave: Neue Diätpille kurz vor Zulassung?
FDA Contrave noch mit dem Argument zurückgewiesen, dass vor einer Zulassung eine grosse Studie das Risiko der Diätpille für Herz-Kreislauf Erkrankungen
FDA Cleared LipoSonix To Be Acquired By Solta Medical
LipoSonix device to be acquired by Solta Medical Company. Solta Medical announced today it’s acquisition of the recently FDA cleared LipoSonix non-invasive
FDA Panel Calls for Silicone Breast Implant Registry
implants for at least a decade after they had the surgery. The two companies that manufacture silicone implants — Allergan and Mentor — are required to
Breast Implant Follow-Up Far Short of FDA Goals
implants to collect better follow-up data, the results are falling woefully short, according to testimony heard during the first day of a two-day meeting of
Breast Implant Safety to Be Focus of FDA Panel
implants years after a woman has received them. FDA’s General and Plastic Surgery Devices Panel on Tuesday and Wednesday will discuss whether current studies